Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value:
$351.51M
Total Bought:
$0
Total Sold:
$32.34M
Net Transaction:
-$32.34M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Sionna Therapeutics, Inc.(SION)2,478,0302,478,0300$101.95M$99.34M28.26%-$2.60M
Immunome, Inc.(IMNM)4,768,5833,613,799-1,154,784$102.43M$79.03M22.48%-$23.40M
Zenas BioPharma, Inc.(ZBIO)3,919,1593,919,1590$142.30M$76.62M21.80%-$65.69M
Compass Therapeutics, Inc.(CMPX)7,788,1507,788,1500$41.82M$41.20M11.72%-$623.1K
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,626,9462,626,9460$32.89M$23.51M6.69%-$9.38M
Upstream Bio, Inc.(UPB)2,459,7032,459,7030$66.78M$22.14M6.30%-$44.64M
CAMP4 THERAPEUTICS CORPORATION(CAMP)3,035,8252,190,920-844,905$18.61M$9.66M2.75%-$8.95M
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q1 2026 | TickerTrail